William D Schmitz

Texas A & M University, College Station, TX, United States

Daniel Romo	grad student		Texas A & M
Albert I. Meyers	post-doc		Colorado State

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Hill MD, Fang H, Norris D, et al. (2022) Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic Properties. Acs Medicinal Chemistry Letters. 13: 1165-1171
Schmitz WD, Brenner AB, Bronson JJ, et al. (2010) 5-arylamino-1,2,4-triazin-6(1H)-one CRF1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20: 3579-83
Hartz RA, Ahuja VT, Schmitz WD, et al. (2010) Synthesis and structure-activity relationships of N3-pyridylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20: 1890-4
Hartz RA, Ahuja VT, Arvanitis AG, et al. (2009) Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists. Journal of Medicinal Chemistry. 52: 4173-91
Hartz RA, Ahuja VT, Rafalski M, et al. (2009) In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. Journal of Medicinal Chemistry. 52: 4161-72
Schmitz WD, Denhart DJ, Brenner AB, et al. (2005) Homotryptamines as potent and selective serotonin reuptake inhibitors (SSRIs). Bioorganic & Medicinal Chemistry Letters. 15: 1619-21